AbbVie Inc.

The drug is used for the treatment of respiratory distress syndrome (hyaline membrane disease) in preterm infants. It is also used for the prevention of this condition in children with a body weight of less than 1250 g who are at risk of developing the disease or show signs of surfactant deficiency.

Dosage form: suspension for intratracheal administration

ATC: R07AA30